PRAX Stock Summary and Trading Ideas (Praxis Precision Medicines | NASDAQ:PRAX)

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

What symbol and exchange does Praxis Precision Medicines shares trade?

Praxis Precision Medicines trades on the NASDAQ stock market under the symbol PRAX.

What is Praxis Precision Medicines stock price doing today?

As of December 4, 2025, PRAX stock price climbed to $189.97 with 800,383 million shares trading.

What is Praxis Precision Medicines's Beta?

PRAX has a beta of 2.07, meaning it tends to be more sensitive to market movements. PRAX has a correlation of 0.05 to the broad based SPY ETF.

How much is Praxis Precision Medicines worth?

PRAX has a market cap of $4.75 billion. This is considered a Mid Cap stock.

How much money does Praxis Precision Medicines make?

Last quarter Praxis Precision Medicines reported $0 in Revenue and -$3.36 earnings per share. This fell short of revenue expectation by $-59,440 and exceeded earnings estimates by $.11.

What is the highest and lowest price Praxis Precision Medicines traded in the last 3 year period?

In the last 3 years, PRAX traded as high as $206.71 and as low as $11.85.

What are the top ETFs holding Praxis Precision Medicines?

The top ETF exchange traded funds that PRAX belongs to (by Net Assets): VTI, XBI, IWM, VXF, IBB.

Is Praxis Precision Medicines (PRAX) a good investment?

PRAX has outperformed the market in the last year with a return of +163.4%, while the SPY ETF gained +14.5%. In the last 3 month period, PRAX beat the market returning +308.1%, while SPY returned +6.6%. However, in the most recent 2 weeks PRAX has underperformed the stock market by returning +0.3%, while SPY returned +3.3%.

What are the support and resistance levels for Praxis Precision Medicines (PRAX)?

PRAX support price is $175.19 and resistance is $197.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRAX shares will trade within this expected range on the day.